Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (425)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Barkhof, F.
Right arrow Articles by Valk, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barkhof, F.
Right arrow Articles by Valk, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 11 2059-2069, Copyright © 1997 by Oxford University Press


REVIEWS

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

F Barkhof, M Filippi, DH Miller, P Scheltens, A Campi, CH Polman, G Comi, HJ Ader, N Losseff and J Valk
Department of Diagnostic Radiology, Vrije Universiteit Hospital, Amsterdam, The Netherlands.

We compared MRI criteria used to predict conversion of suspected multiple sclerosis to clinically definite multiple sclerosis. Seventy- four patients with clinically isolated neurological symptoms suggestive of multiple sclerosis were studied with MRI. Logistic regression analysis was used to remove redundant information, and a diagnostic model was built after each MRI parameter was dichotomized according to maximum accuracy using receiver operating characteristic analysis. Clinically definite multiple sclerosis developed in 33 patients (prevalence 45%). The optimum cut-off point (number of lesions) was one for most MRI criteria (including gadolinium-enhancement and juxta- cortical lesions), but three for periventricular lesions, and nine for the total number of T2-lesions. Only gadolinium-enhancement and juxta- cortical lesions provided independent information. A final model which, in addition, included infratentorial and periventricular lesions, had an accuracy of 80%, and having more abnormal criteria, predicted conversion to clinically definite multiple sclerosis strongly. The model performed better than the criteria of Paty et al. (Neurology 1988; 38: 180-5) and of Fazekas et al. (Neurology 1988; 38: 1822-5). We concluded that a four-parameter dichotomized MRI model including gadolinium-enhancement, juxtacortical, infratentorial and periventricular lesions best predicts conversion to clinically definite multiple sclerosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
B. Moraal, C. Pohl, B. M. J. Uitdehaag, C. H. Polman, G. Edan, M. S. Freedman, H.-P. Hartung, L. Kappos, D. H. Miller, X. Montalban, et al.
Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Arch Neurol, November 1, 2009; 66(11): 1345 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
O. Outteryck, H. Zephir, S. Defoort, M. Bouyon, P. Debruyne, I. Bouacha, D. Ferriby, A. Lacour, P. Labalette, J. de Seze, et al.
Optical Coherence Tomography in Clinically Isolated Syndrome: No Evidence of Subclinical Retinal Axonal Loss
Arch Neurol, November 1, 2009; 66(11): 1373 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. Young, S. Quinn, M. Hurrell, and B. Taylor
Clinically isolated acute transverse myelitis: prognostic features and incidence
Multiple Sclerosis, November 1, 2009; 15(11): 1295 - 1302.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C-P Lo, H-W Kao, S-Y Chen, C-J Hsueh, W-C Lin, W-L Hsu, D-K Wu, and G-C Liu
Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria
J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1107 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. Goodin and D. Bates
Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
Multiple Sclerosis, October 1, 2009; 15(10): 1175 - 1182.
[Abstract] [PDF]


Home page
LupusHome page
S Appenzeller, M Veilleux, and A Clarke
Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus
Lupus, August 1, 2009; 18(9): 836 - 840.
[Abstract] [PDF]


Home page
Mult SclerHome page
A Siva, S Saip, A Altintas, A Jacob, B. Keegan, and O. Kantarci
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease
Multiple Sclerosis, August 1, 2009; 15(8): 918 - 927.
[Abstract] [PDF]


Home page
Arch NeurolHome page
C. Lebrun, C. Bensa, M. Debouverie, S. Wiertlevski, D. Brassat, J. de Seze, L. Rumbach, J. Pelletier, P. Labauge, B. Brochet, et al.
Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-up of 70 Patients
Arch Neurol, July 1, 2009; 66(7): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
T Matsushita, N Isobe, T Matsuoka, N Shi, Y Kawano, X. Wu, T Yoshiura, Y Nakao, T Ishizu, and J. Kira
Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese
Multiple Sclerosis, July 1, 2009; 15(7): 834 - 847.
[Abstract] [PDF]


Home page
Mult SclerHome page
J. Cabrera-Gomez, M Bonnan, A Gonzalez-Quevedo, A Saiz-Hinarejos, R Marignier, S Olindo, F Graus, D Smadja, H Merle, L Thomas, et al.
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies
Multiple Sclerosis, July 1, 2009; 15(7): 828 - 833.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Nakamura, T Misu, K Fujihara, I Miyazawa, I Nakashima, T Takahashi, S Watanabe, and Y Itoyama
Occurrence of acute large and edematous callosal lesions in neuromyelitis optica
Multiple Sclerosis, June 1, 2009; 15(6): 695 - 700.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al.
A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol, May 1, 2009; 66(5): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Boster, S. Hreha, J. R. Berger, F. Bao, R. Penmesta, A. Tselis, C. Endress, I. Zak, J. Perumal, C. Caon, et al.
Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol, May 1, 2009; 66(5): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
H Zephir, D Lefranc, S Dubucquoi, J de Seze, L Boron, L Prin, and P Vermersch
Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis
Multiple Sclerosis, May 1, 2009; 15(5): 593 - 600.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Freedman, J Laks, N Dotan, R. Altstock, A Dukler, and C. Sindic
Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event
Multiple Sclerosis, April 1, 2009; 15(4): 422 - 430.
[Abstract] [PDF]


Home page
Mult SclerHome page
V Zipoli, B Hakiki, E Portaccio, F Lolli, G Siracusa, M Giannini, L Pantoni, F Pescini, S Sorbi, and M. Amato
The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis
Multiple Sclerosis, April 1, 2009; 15(4): 472 - 478.
[Abstract] [PDF]


Home page
NeurologyHome page
D.J.A. Callen, M. M. Shroff, H. M. Branson, T. Lotze, D. K. Li, D. Stephens, and B. L. Banwell
MRI in the diagnosis of pediatric multiple sclerosis
Neurology, March 17, 2009; 72(11): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Zhang, J. Jin, Y. Tang, D. Speer, D. Sujkowska, and S. Markovic-Plese
IFN-{beta}1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation
J. Immunol., March 15, 2009; 182(6): 3928 - 3936.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. T. Okuda, E. M. Mowry, A. Beheshtian, E. Waubant, S. E. Baranzini, D. S. Goodin, S. L. Hauser, and D. Pelletier
Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome
Neurology, March 3, 2009; 72(9): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Bourdette and J. Simon
The radiologically isolated syndrome: Is it very early multiple sclerosis?
Neurology, March 3, 2009; 72(9): 780 - 781.
[Full Text] [PDF]


Home page
Mult SclerHome page
M Atzori, P. Battistella, P Perini, M Calabrese, M Fontanin, A. Laverda, A Suppiej, P Drigo, P Grossi, L Rinaldi, et al.
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study
Multiple Sclerosis, March 1, 2009; 15(3): 363 - 370.
[Abstract] [PDF]


Home page
Mult SclerHome page
J. Cabrera-Gomez, L Ramon-Perez, A Saiz, P Llerena-Fernandez, L Fernandez-Fernandez, G Ercilla, D Grass-Fernandez, M. Robinson-Agramonte, K Romero-Garcia, R Macias-Betancourt, et al.
Neuromyelitis optica and multiple sclerosis in sisters
Multiple Sclerosis, February 1, 2009; 15(2): 269 - 271.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Osoegawa, J Kira, T Fukazawa, K Fujihara, S Kikuchi, M Matsui, T Kohriyama, G Sobue, T Yamamura, Y Itoyama, et al.
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years
Multiple Sclerosis, February 1, 2009; 15(2): 159 - 173.
[Abstract] [PDF]


Home page
NeurologyHome page
T. Kumpfel, L-A Hoffmann, H. Pellkofer, W. Pollmann, W. Feneberg, R. Hohlfeld, and P. Lohse
Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases
Neurology, November 25, 2008; 71(22): 1812 - 1820.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
T Matsuoka, T Matsushita, M Osoegawa, Y Kawano, M Minohara, F Mihara, Y Nishimura, Y Ohyagi, and J Kira
Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis
Multiple Sclerosis, November 1, 2008; 14(9): 1181 - 1190.
[Abstract] [PDF]


Home page
Mult SclerHome page
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al.
Differential diagnosis of suspected multiple sclerosis: a consensus approach
Multiple Sclerosis, November 1, 2008; 14(9): 1157 - 1174.
[Abstract] [PDF]


Home page
NeurologyHome page
M. Tanaka, T. Matsushita, T. Tateishi, H. Ochi, Y. Kawano, F. -J. Mei, M. Minohara, H. Murai, and J. -i. Kira
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
Neurology, September 23, 2008; 71(13): 974 - 981.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Zephir, T Stojkovic, P Latour, A Lacour, J de Seze, O Outteryck, C-A Maurage, C Monpeurt, P Chatelet, E Ovelacq, et al.
Relapsing demyelinating disease affecting both the central and peripheral nervous systems
J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1032 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Z. Liptak, A.M. Berger, M.P. Sampat, A. Charil, O. Felsovalyi, B.C. Healy, P. Hildenbrand, S.J. Khoury, H.L. Weiner, R. Bakshi, et al.
Medulla Oblongata Volume: A Biomarker of Spinal Cord Damage and Disability in Multiple Sclerosis
AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1465 - 1470.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Bendszus, G. Ladewig, L. Jestaedt, B. Misselwitz, L. Solymosi, K. Toyka, and G. Stoll
Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study
Brain, September 1, 2008; 131(9): 2341 - 2352.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
T. Okamoto, M. Ogawa, Youwei Lin, M. Murata, S. Miyake, and T. Yamamura
Review: Treatment of neuromyelitis optica: Current debate
Therapeutic Advances in Neurological Disorders, July 1, 2008; 1(1): 43 - 52.
[Abstract] [PDF]


Home page
Mult SclerHome page
D Bar-Zohar, F Agosta, D Goldstaub, and M Filippi
Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
Multiple Sclerosis, July 1, 2008; 14(6): 719 - 727.
[Abstract] [PDF]


Home page
Mult SclerHome page
A Boster, C Caon, J Perumal, S Hreha, R Zabad, I Zak, A Tselis, R Lisak, and O Khan
Failure to develop multiple sclerosis in patients with neurologic symptoms without objective evidence
Multiple Sclerosis, July 1, 2008; 14(6): 804 - 808.
[Abstract] [PDF]


Home page
Mult SclerHome page
A Javed, R Balabanov, B. Arnason, T. Kelly, N. Sweiss, P Pytel, R Walsh, E. Blair, A Stemer, M Lazzaro, et al.
Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis
Multiple Sclerosis, July 1, 2008; 14(6): 809 - 814.
[Abstract] [PDF]


Home page
BrainHome page
C. F. Lucchinetti, R. H. Gavrilova, I. Metz, J. E. Parisi, B. W. Scheithauer, S. Weigand, K. Thomsen, J. Mandrekar, A. Altintas, B. J. Erickson, et al.
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis
Brain, July 1, 2008; 131(7): 1759 - 1775.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Jilek, M. Schluep, P. Meylan, F. Vingerhoets, L. Guignard, A. Monney, J. Kleeberg, G. Le Goff, G. Pantaleo, and R. A. Du Pasquier
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Brain, July 1, 2008; 131(7): 1712 - 1721.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M. Simo, P. Barsi, and Z. Aranyi
Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria
Multiple Sclerosis, May 1, 2008; 14(4): 472 - 478.
[Abstract] [PDF]


Home page
Mult SclerHome page
T. Matsushita, T. Matsuoka, T. Ishizu, H. Kikuchi, M. Osoegawa, Y. Kawano, F. Mihara, Y. Ohyagi, and J.-i. Kira
Anterior periventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study
Multiple Sclerosis, April 1, 2008; 14(3): 343 - 353.
[Abstract] [PDF]


Home page
NeurologyHome page
R. Q. Hintzen and G. Giovannoni
CSF analysis in suspected MS: Do bands aid?
Neurology, March 25, 2008; 70(13_Part_2): 1059 - 1060.
[Full Text] [PDF]


Home page
Mult SclerHome page
J. Cabrera-Gomez, A. Saiz-Hinarejos, F. Graus, A. Gonzalez-Quevedo, R. Rodriguez-Rojas, L. Quevedo-Sotolongo, Y. Real-Gonzalez, D. Grass-Fernandez, M. Cristofol-Corominas, M. Rodriguez-Cordero, et al.
Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders
Multiple Sclerosis, March 1, 2008; 14(2): 248 - 251.
[Abstract] [PDF]


Home page
Postgrad. Med. J.Home page
A Theodoridou and L Settas
Demyelination in rheumatic diseases
Postgrad. Med. J., March 1, 2008; 84(989): 127 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Lebrun, C Bensa, M Debouverie, J De Seze, S Wiertlievski, B Brochet, P Clavelou, D Brassat, P Labauge, E Roullet, et al.
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 195 - 198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
D.S. Reich, K.M. Zackowski, E.M. Gordon-Lipkin, S.A. Smith, B.A. Chodkowski, G.R. Cutter, and P.A. Calabresi
Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 333 - 339.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
V. Tomassini, L. De Giglio, M. Reindl, P. Russo, I. Pestalozza, P. Pantano, T. Berger, and C. Pozzilli
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
Multiple Sclerosis, November 1, 2007; 13(9): 1086 - 1094.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Calabrese, N. De Stefano, M. Atzori, V. Bernardi, I. Mattisi, L. Barachino, A. Morra, L. Rinaldi, C. Romualdi, P. Perini, et al.
Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis
Arch Neurol, October 1, 2007; 64(10): 1416 - 1422.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.P. Wattjes, M. Harzheim, G.G. Lutterbey, L. Klotz, H.H. Schild, and F. Traber
Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1517 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R. Pelayo, M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, M. Comabella, and X. Montalban
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort
Multiple Sclerosis, July 1, 2007; 13(6): 731 - 736.
[Abstract] [PDF]


Home page
ImagingHome page
R M S CARTER and P M PRETORIUS
The use of CT and MRI in the characterization of intracranial mass lesions
Imaging, June 1, 2007; 19(2): 173 - 184.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
T. Matsuoka, T. Matsushita, Y. Kawano, M. Osoegawa, H. Ochi, T. Ishizu, M. Minohara, H. Kikuchi, F. Mihara, Y. Ohyagi, et al.
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese
Brain, May 1, 2007; 130(5): 1206 - 1223.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
Y. Mikaeloff, G. Caridade, S. Assi, M. Tardieu, S. Suissa, and on behalf of the KIDSEP study group of the French
Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination
Brain, April 1, 2007; 130(4): 1105 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. A Cabrera-Gomez, L Quevedo-Sotolongo, A Gonzalez-Quevedo, S Lima, Y Real-Gonzalez, M Cristofol-Corominas, K Romero-Garcia, C Ugarte-Sanchez, J Jordan-Gonzalez, J E G. de la Nuez, et al.
Brain magnetic resonance imaging findings in relapsing neuromyelitis optica
Multiple Sclerosis, March 1, 2007; 13(2): 186 - 192.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
O. Gonen, T.A. Oberndorfer, M. Inglese, J.S. Babb, J. Herbert, and R.I. Grossman
Reproducibility of Three Whole-Brain N-Acetylaspartate Decline Cohorts in Relapsing-Remitting Multiple Sclerosis
AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 267 - 271.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Jurewicz, M. Matysiak, C. S. Raine, and K. Selmaj
Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis
Neurology, January 23, 2007; 68(4): 283 - 287.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Puccioni-Sohler, Y. Yamano, M. Rios, S.M.F. Carvalho, C. C.F. Vasconcelos, R. Papais-Alvarenga, and S. Jacobson
Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I
Neurology, January 16, 2007; 68(3): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.P. Wattjes, G.G. Lutterbey, J. Gieseke, F. Traber, L. Klotz, S. Schmidt, and H.H. Schild
Double Inversion Recovery Brain Imaging at 3T: Diagnostic Value in the Detection of Multiple Sclerosis Lesions
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 54 - 59.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Kappos, C. H. Polman, M. S. Freedman, G. Edan, H. P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, L. Bauer, P. Jakobs, et al.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
Neurology, October 10, 2006; 67(7): 1242 - 1249.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, R. Pelayo, M. Comabella, J. Sastre-Garriga, and X. Montalban
Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
Neurology, September 26, 2006; 67(6): 968 - 972.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Imrell, A.-M. Landtblom, J. Hillert, and T. Masterman
Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct.
Neurology, September 26, 2006; 67(6): 1062 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.P. Wattjes, M. Harzheim, C.K. Kuhl, J. Gieseke, S. Schmidt, L. Klotz, T. Klockgether, H.H. Schild, and G.G. Lutterbey
Does High-field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis?
AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1794 - 1798.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Y. Mikaeloff, G. Caridade, S. Assi, S. Suissa, M. Tardieu, and on behalf of the KIDSEP Study Group
Prognostic Factors for Early Severity in a Childhood Multiple Sclerosis Cohort
Pediatrics, September 1, 2006; 118(3): 1133 - 1139.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. Rinaldi, P. Gallo, M. Calabrese, F. Ranzato, D. Luise, D. Colavito, M. Motta, A. Guglielmo, E. Del Giudice, C. Romualdi, et al.
Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
Brain, August 1, 2006; 129(Pt 8): 1993 - 2007.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J K Swanton, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, and D H Miller
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes
J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 830 - 833.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
P. S. Sorensen, N. Koch-Henriksen, M. Ravnborg, J. L. Frederiksen, K a. Jensen, A. Heltberg, H. Schaldemose, S. Deth, O l. Kristensen, M. Worm, et al.
Immunomodulatory treatment of multiple sclerosis in Denmark: a prospective nationwide survey
Multiple Sclerosis, June 1, 2006; 12(3): 253 - 264.
[Abstract] [PDF]


Home page
Arch NeurolHome page
C. Fraser, A. Klistorner, S. Graham, R. Garrick, F. Billson, and J. Grigg
Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
Arch Neurol, June 1, 2006; 63(6): 847 - 850.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Inglese
Multiple sclerosis: new insights and trends.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 954 - 957.
[Full Text] [PDF]


Home page
BMJHome page
P. Whiting, R. Harbord, C. Main, J. J Deeks, G. Filippini, M. Egger, and J. A C Sterne
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review
BMJ, April 15, 2006; 332(7546): 875 - 884.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Vrenken, S.A.R.B. Rombouts, P.J.W. Pouwels, and F. Barkhof
Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 868 - 874.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Brettschneider, A Petzold, A Junker, and H Tumani
Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
Multiple Sclerosis, April 1, 2006; 12(2): 143 - 148.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Theodoridou and L Settas
Demyelination in rheumatic diseases.
J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 290 - 295.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. J. Pittock, V. A. Lennon, K. Krecke, D. M. Wingerchuk, C. F. Lucchinetti, and B. G. Weinshenker
Brain abnormalities in neuromyelitis optica.
Arch Neurol, March 1, 2006; 63(3): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Masjuan, J. C. Alvarez-Cermeno, N. Garcia-Barragan, M. Diaz-Sanchez, M. Espino, M. C. Sadaba, P. Gonzalez-Porque, J. M. San Millan, and L. M. Villar
Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS
Neurology, February 28, 2006; 66(4): 576 - 578.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
F. Barkhof, U. Held, J. H. Simon, M. Daumer, F. Fazekas, M. Filippi, J. A. Frank, L. Kappos, D. Li, S. Menzler, et al.
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials
Neurology, November 8, 2005; 65(9): 1447 - 1454.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S A Trip and D H Miller
Imaging in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(suppl_3): iii11 - iii18.
[Full Text] [PDF]


Home page
Mult SclerHome page
I F Pestalozza, C Pozzilli, S Di Legge, M C Piattella, P Pantano, F Caramia, P Pasqualetti, and G L Lenzi
Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome
Multiple Sclerosis, August 1, 2005; 11(4): 390 - 394.
[Abstract] [PDF]


Home page
RadiologyHome page
J. J. G. Geurts, P. J. W. Pouwels, B. M. J. Uitdehaag, C. H. Polman, F. Barkhof, and J. A. Castelijns
Intracortical Lesions in Multiple Sclerosis: Improved Detection with 3D Double Inversion-Recovery MR Imaging
Radiology, July 1, 2005; 236(1): 254 - 260.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Gallo, M. Rovaris, R. Riva, A. Ghezzi, B. Benedetti, V. Martinelli, A. Falini, G. Comi, and M. Filippi
Diffusion-Tensor Magnetic Resonance Imaging Detects Normal-Appearing White Matter Damage Unrelated to Short-term Disease Activity in Patients at the Earliest Clinical Stage of Multiple Sclerosis
Arch Neurol, May 1, 2005; 62(5): 803 - 808.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. J. Carmosino, K. M. Brousseau, D. B. Arciniegas, and J. R. Corboy
Initial Evaluations for Multiple Sclerosis in a University Multiple Sclerosis Center: Outcomes and Role of Magnetic Resonance Imaging in Referral
Arch Neurol, April 1, 2005; 62(4): 585 - 590.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. Ferreira, D. P. D'Cruz, and G. R. V. Hughes
Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?
Rheumatology, April 1, 2005; 44(4): 434 - 442.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Laura, W. Leong, N. M.F. Murray, G. Ingle, K. A. Miszkiel, D. R. Altmann, D. H. Miller, and M. M. Reilly
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord
Neurology, March 8, 2005; 64(5): 914 - 916.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C. H Polman, J. S Wolinsky, and S. C Reingold
Multiple sclerosis diagnostic criteria: three years later
Multiple Sclerosis, February 1, 2005; 11(1): 5 - 12.
[Abstract] [PDF]


Home page
NeurologyHome page
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
Neurology, December 14, 2004; 63(11_suppl_5): S3 - S11.
[Abstract] [Full Text]


Home page
NeurologyHome page
W. H. Stuart, S. Cohan, J. R. Richert, and A. Achiron
Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis
Neurology, December 14, 2004; 63(11_suppl_5): S19 - S27.
[Abstract] [Full Text]


Home page
Mult SclerHome page
M Colucci, L Roccatagliata, E Capello, E Narciso, N Latronico, M Tabaton, and G L Mancardi
The 14-3-3 protein in multiple sclerosis: a marker of disease severity
Multiple Sclerosis, October 1, 2004; 10(5): 477 - 481.
[Abstract] [PDF]


Home page
Mult SclerHome page
A. Kheradvar, A. R. Tabassi, B. Nikbin, F. Khosravi, M. Naroueynejad, B. Moradi, and A. A. Amirzargar
Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study
Multiple Sclerosis, October 1, 2004; 10(5): 526 - 531.
[Abstract] [PDF]


Home page
Arch NeurolHome page
Optic Neuritis Study Group
Long-term Brain Magnetic Resonance Imaging Changes After Optic Neuritis in Patients Without Clinically Definite Multiple Sclerosis
Arch Neurol, October 1, 2004; 61(10): 1538 - 1541.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. M. J. Uitdehaag, J. J. G. Geurts, F. Barkhof, C. H. Polman, D. S. Goodin, and E. M. Frohman
The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee
Neurology, September 28, 2004; 63(6): 1140 - 1140.
[Full Text] [PDF]


Home page
BrainHome page
Y. Mikaeloff, C. Adamsbaum, B. Husson, L. Vallee, G. Ponsot, C. Confavreux, M. Tardieu, S. Suissa, and the KIDMUS Study Group on Radiology
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood
Brain, September 1, 2004; 127(9): 1942 - 1947.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. T. M. Fernando, M. A. McLean, D. T. Chard, D. G. MacManus, C. M. Dalton, K. A. Miszkiel, R. M. Gordon, G. T. Plant, A. J. Thompson, and D. H. Miller
Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis
Brain, June 1, 2004; 127(6): 1361 - 1369.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D.-A. Laplaud, C. Ruiz, S. Wiertlewski, S. Brouard, L. Berthelot, M. Guillet, B. Melchior, N. Degauque, G. Edan, P. Brachet, et al.
Blood T-cell receptor {beta} chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution
Brain, May 1, 2004; 127(5): 981 - 995.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. D. Hahn, M. M. Shroff, S. I. Blaser, and B. L. Banwell
MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort
Neurology, March 9, 2004; 62(5): 806 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Goffette, M Schluep, H Henry, T Duprez, and C J M Sindic
Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 308 - 310.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Minneboo, F. Barkhof, C. H. Polman, B. M. J. Uitdehaag, D. L. Knol, and J. A. Castelijns
Infratentorial Lesions Predict Long-term Disability in Patients With Initial Findings Suggestive of Multiple Sclerosis
Arch Neurol, February 1, 2004; 61(2): 217 - 221.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Sastre-Garriga, M. Tintore, A. Rovira, C. Nos, J. Rio, A. J. Thompson, and X. Montalban
Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
Arch Neurol, February 1, 2004; 61(2): 222 - 224.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. C.J. Bot, F. Barkhof, C. H. Polman, G.J. L. a Nijeholt, V. de Groot, E. Bergers, H. J. Ader, and J. A. Castelijns
Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination
Neurology, January 27, 2004; 62(2): 226 - 233.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.